Journals / Turkish Journal of Surgery / 2020 / Cilt: 36 - Sayı: 4

Lymph node mapping in gastric cancer surgery: current status and new horizons

Mide kanseri cerrahisinde lenf bezi haritalaması: güncel durum ve yeni ufuklar

Pages
393–398
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Despite its notable limitations, SLN mapping andSLN navigation surgery present a novelty individualizing the extent of lymphadenectomy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gastric cancer (GC) remains one of the most important malignant diseases with significant geographical, ethnic, and socioeconomic differences indistribution.
📊
Key Findings & Data:Sentinel lymph node (SLN) mapping is an accepted way to assess lymphatic spread in several solid tumors; however, the complexity ofgastric lymphatic drainage may discourage use of this procedure, and the estimated accuracy rate is, in general, reasonably good.
💡
Conclusion & Impact:Despite its notable limitations, SLN mapping andSLN navigation surgery present a novelty individualizing the extent of lymphadenectomy.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gastric cancer (GC) remains one of the most important malignant diseases with significant geographical, ethnic, and socioeconomic differences indistribution. Sentinel lymph node (SLN) mapping is an accepted way to assess lymphatic spread in several solid tumors; however, the complexity ofgastric lymphatic drainage may discourage use of this procedure, and the estimated accuracy rate is, in general, reasonably good. This study aimed atreviewing the current status of SLN mapping and navigation surgery in GC. SLN mapping should be limited to tumors clinically T1 and less than 4 cmin diameter. Combination SLN mapping with radioactive colloid and blue dye is used as the standard. Despite its notable limitations, SLN mapping andSLN navigation surgery present a novelty individualizing the extent of lymphadenectomy.

Özet

Gastrik kanser (GC), dağılımda önemli coğrafi, etnik ve sosyoekonomik farklılıklara sahip en önemli malign hastalıklardan biri olmaya devam etmektedir. Sentinel lenf nodu (SLN) haritalaması, bazı solid tümörlerde lenfatik yayılımı değerlendirmenin kabul edilen bir yoludur, gastrik lenfatik drenajın karmaşıklığı bu prosedürün kullanımını engelleyebilir, tahmini doğruluk oranı genel olarak makul derecede iyidir. GC’de SLN haritalama ve navigasyon cerrahisinin mevcut durumu gözden geçirilmektedir. SLN haritalaması klinik T1 ve çapı 4 cm’den küçük tümörler ile sınırlı olmalıdır. Radyoaktif kolloid ve mavi boya ile kombinasyon SLN haritalaması standart olarak kullanılır. Kayda değer sınırlamalarına rağmen, SLN haritalaması ve SLN navigasyon cerrahisi lenfadenektomiyi kişiselleştiren bir yenilik sunmaktadır.

🔖

Cite This Article

ÖZMEN, M., ZÜLFİKAROĞLU, B., SOYDAL, Ç., KÜÇÜK, Ö. (2022). Lymph node mapping in gastric cancer surgery: current status and new horizons. Turkish Journal of Surgery, Cilt: 36 - Sayı: 4, 393–398. https://ajindex.com/articles/614286

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Rothbarth J, Wijnhoven B. Lymphatic dissemination and the role of sentinel lymph node biopsy in early gastric cancer. Dig Surg 2012
  2. [CrossRef] 2. Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: current status of diagnosis and treatment. Cancers 2013
  3. [CrossRef] 3. Niebling M, Pleijhuis R, Bastiaannet E, Brouwers A, van Dam G, Hoekstra H. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol 2016
  4. [CrossRef] 4. Giuliani A, Miccini M, Basso L. Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer. World J Gastroenterol 2014
  5. [CrossRef] 5. Association JGC. Japanese classification of gastric carcinoma -2nd English edition-. Gastric Cancer 1998
  6. [CrossRef] 6. Wu C, Hsiung C, Lo S, Hsieh M, Shia L, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004
  7. [CrossRef] 7. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AFY, Lui WY, Whang- Peng J. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006
  8. [CrossRef] 8. Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 2008
  9. [CrossRef] 9. Hartgrink H, Van de Velde C, Putter H, Bonenkamp J, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004
  10. [CrossRef] 10. Songun I, Putter H, Kranenbarg EMK, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010
  11. [CrossRef] 11. Degiuli M, Sasako M, Ponti A. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg 2010
  12. [CrossRef] 12. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? Langenbecks Arch Surg 1999
  13. [CrossRef] 13. Kitagawa Y, Ohgami M, Fujii H, Mukai M, Kubota T, Ando N, et al. Laparoscopic detection of sentinel lymph nodes in gastrointestinal can